Zacks Investment Research upgraded shares of CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $2.25 target price on the stock.
According to Zacks, “Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada. “
Get CYBIN INC. (CYBN.NE) alerts:
OTCMKTS CYBN opened at $1.92 on Tuesday. CYBIN INC. has a 52-week low of $0.49 and a 52-week high of $3.38. The stock has a market cap of $305.89 million and a P/E ratio of -8.00.
Top 10 Heal Care Stocks To Buy Right Now: Turkcell Iletisim Hizmetleri AS(TKC)
Turkcell Iletisim Hizmetleri A.S. engages in establishing and operating a global system for mobile communications network in Turkey. It provides mobile voice, and Internet services over its mobile communications network; voice services, which include wireless telephone services on a prepaid and postpaid basis; mobile Internet and 3G services; consumer services; Telco services; TV and video services; music services; infotainment services; social community and other services; and mobile financial services The company also offers Turkcell enablers and platforms; corporate (B2B); corporate telco; authentication; location based; mobile marketing; machine-to-machine communications; and international roaming services. In addition, it provides Mobile Signature, a GSM service that enables customers to sign electronic documents and transactions with a legally-accepted digital signature using GSM SIM cards; and Mobile Billboard, which enables brands to reach their targeted customers . As of December 31, 2010, the company had approximately 23.3 million prepaid subscribers and 10.1 million postpaid subscribers. It sells its products and services through its distribution network consists of distributors, Turkcell distribution centers, corporate solution centers, non exclusive dealers, Turkcell communication centers, Turkcell stores, and consumer electronic Chains, as well as points of sale for prepaid airtime, including ATMs, POS, Web, call centers, supermarkets, and kiosks. The company was founded in 1993 and is headquartered in Istanbul, Turkey. Turkcell Iletisim Hizmetleri AS is a subsidiary of Turkcell Holding A.S.
Advisors’ Opinion:
- [By Logan Wallace]
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) and CHORUS LTD/S (OTCMKTS:CHRYY) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.
- [By Logan Wallace]
WARNING: “Turkcell Iletisim Hizmetleri A.S. (TKC) Trading Down 8.4% After Earnings Miss” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at www.tickerreport.com/banking-finance/4169538/turkcell-iletisim-hizmetleri-a-s-tkc-trading-down-8-4-after-earnings-miss.html.
- [By Rich Smith]
Shares of Turkish telecom Turkcell Iletisim Hizmetleri (NYSE:TKC) plummeted 10% to close at $4.42 per share on Thursday — then proceeded to slide more after-hours. Perhaps worse for investors trying to figure out how to react to this news: There was no obvious reason for the decline.
- [By Rich Smith]
Turkish telco Turkcell Iletisim Hizmetleri (NYSE:TKC)closed up 11.6% on Thursday after the country’s central bank announced a big boost to interest rates — 24%, or 6.25 percentage points more than previously — boosting the Turkish lira’s value against the U.S. dollar for the third straight day.
Top 10 Heal Care Stocks To Buy Right Now: Neovasc Inc.(NVCN)
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina.
In 2009, Neovasc started initial activities to develop novel technologies for catheter-based treatment of mitral valve disease. Based on the early positive results of these activities, the Company formally launched a program to develop the Tiara. Neovasc established a separate entity, Neovasc Tiara Inc. (NTI), in March 2013 to develop and own the intellectual property related to the Tiara (Neovasc has transferred all intellectual property related to Tiara to NTI). On February 3, 2014, Neovasc announced the first human implant of the Tiara under special access compassionate use exemptions. Advisors’ Opinion:
- [By Max Byerly]
Neovasc Inc (NASDAQ:NVCN) (TSE:NVC) shares dropped 10% during trading on Monday . The company traded as low as $2.38 and last traded at $2.65. Approximately 3,137 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 507,141 shares. The stock had previously closed at $2.41.
- [By Logan Wallace]
Cerus (NASDAQ:CERS) and Neovasc (NASDAQ:NVCN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.
- [By Logan Wallace]
Neovasc Inc (NASDAQ:NVCN) (TSE:NVC) traded down 14.3% during trading on Tuesday . The company traded as low as $2.60 and last traded at $2.69. 1,108,600 shares traded hands during trading, an increase of 141% from the average session volume of 459,569 shares. The stock had previously closed at $3.14.
Top 10 Heal Care Stocks To Buy Right Now: DraftKings Inc.(DKNG)
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States. It operates through two segments, Business-to-Consumer and Business-to-Business. The company provides users with daily sports, sports betting, and iGaming opportunities. It is also involved in the design, development, and licensing of sports betting and casino gaming platform software for online and retail sportsbook, and casino gaming products. The company distributes its product offerings through various channels, including traditional websites and direct app downloads, as well as direct-to-consumer digital platforms, such as the Apple App store and the Google Play store. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
Advisors’ Opinion:
- [By Dana Blankenhorn]
If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).
Top 10 Heal Care Stocks To Buy Right Now: Mechel OAO(MTL)
We are a vertically integrated group with revenues of RUB 253,141 million in 2015 and RUB 243,992 million in 2014, with operations organized into three industrial segments: mining, steel and power, each of which has a management company that performs the functions of respective executive management bodies of the companies within the segment, as described below.
Our group includes a number of logistical and marketing companies that help us to deliver and market our products. We have freight seaports in Russia on the Sea of Japan (Port Posiet) and on the Sea of Azov (Port Temryuk) and a freight river port on the Kama River, a tributary of the Volga River in central Russia (Port Kambarka). We have a fleet of freight railcars, locomotives and long-haul trucks, and operate a rail line to our Elga coal deposit in the Sakha Republic. Advisors’ Opinion:
- [By Money Morning News Team]
Mechel Mining Co. (NYSE: MTL) is one of Russia’s largest mining and metal companies, focusing on the production of coal, iron ore, steel and silver.
- [By Logan Wallace]
Media coverage about Mechel PAO (NYSE:MTL) has been trending somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Mechel PAO earned a news impact score of 0.17 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 45.3523753315597 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
- [By Joseph Griffin]
Mullen Group Ltd (TSE:MTL) declared a monthly dividend on Wednesday, June 20th, Zacks reports. Shareholders of record on Saturday, June 30th will be paid a dividend of 0.05 per share on Monday, July 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend is Thursday, June 28th.
Top 10 Heal Care Stocks To Buy Right Now: Stantec Inc(STN)
Stantec Inc. provides professional consulting services in planning, engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics in the areas of infrastructure and facilities for public and private sector clients in North America and internationally. The company involves in the design of healthcare, education, science and technology, airport, retail and commercial, and sports and recreation facilities. Its environmental solutions include water supply, treatment, storage, and distribution; wastewater collection, pumping, treatment, and disposal; watershed management; environmental assessment, documentation, and permitting; ecosystem restoration planning and design; environmental site management and remediation; subsurface investigation and characterization; and geotechnical engineering services. Stantec Inc. also provides industrial planning, functional programming, engineering, project mana gement, and construction support services in oil and gas, fossil and renewable energy, underground mining, linear infrastructure, power transmission and distribution, automotive, forest products, food and beverage, and general manufacturing sectors. In addition, the company prepares transportation master plans for communities; conduct transportation investment studies; plans and designs airport, transit, rail, and highway facilities; and provides administration and support services for the construction of specific projects, and ongoing management planning for the upkeep of transportation facilities, as well as simulation modeling services. Further, it offers urban land solutions for the land development, real estate, and retail and commercial industries, as well as professional services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canad a.
Advisors’ Opinion:
- [By Ethan Ryder]
TRADEMARK VIOLATION NOTICE: “Scotia Capital Inc. Sells 15,249 Shares of Stantec Inc. (STN)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4192654/scotia-capital-inc-sells-15249-shares-of-stantec-inc-stn.html.
- [By Max Byerly]
Shares of Stantec Inc. (TSE:STN) (NYSE:STN) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$31.96 and last traded at C$31.90, with a volume of 125631 shares trading hands. The stock had previously closed at C$32.18.
Top 10 Heal Care Stocks To Buy Right Now: NewMarket Corporation(NEU)
NewMarket Corporation (NewMarket) (NYSE: NEU) is a holding company and is the parent company of Afton Chemical Corporation (Afton), Ethyl Corporation (Ethyl), NewMarket Services Corporation (NewMarket Services), and NewMarket Development Corporation (NewMarket Development). Each of our subsidiaries manages its own assets and liabilities. Afton encompasses the petroleum additives business, while Ethyl represents the sale of tetraethyl lead (TEL) in North America and certain petroleum additives manufacturing operations. NewMarket Development manages the property that we own in Virginia. NewMarket Services provides various administrative services to NewMarket, Afton, Ethyl, and NewMarket Development. NewMarket Services departmental expenses and other expenses are billed to each subsidiary pursuant to services agreements between the companies. Advisors’ Opinion:
- [By Stephan Byrd]
Sino United Worldwide Consolidated (OTCMKTS:SUIC) and NewMarket (NYSE:NEU) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.
- [By Stephan Byrd]
Royce & Associates LP increased its position in shares of NewMarket Co. (NYSE:NEU) by 0.6% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,362 shares of the specialty chemicals company’s stock after purchasing an additional 150 shares during the quarter. Royce & Associates LP owned 0.22% of NewMarket worth $10,663,000 as of its most recent filing with the SEC.
- [By Ethan Ryder]
Here are some of the media stories that may have effected Accern’s rankings:
Get NewMarket alerts:
NewMarket’s (NEU) CEO Teddy Gottwald on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) NEU Crosses Below Key Moving Average Level (nasdaq.com) NewMarket misses by $1.15, misses on revenue (seekingalpha.com) NewMarket Corporation Reports Second Quarter and First Half 2018 Results (finance.yahoo.com) NewMarket: 2Q Earnings Snapshot (finance.yahoo.com)
A number of equities research analysts have weighed in on NEU shares. TheStreet raised NewMarket from a “c” rating to a “b-” rating in a research report on Wednesday, April 25th. ValuEngine lowered NewMarket from a “hold” rating to a “sell” rating in a research report on Saturday, June 2nd.
Top 10 Heal Care Stocks To Buy Right Now: Ampco-Pittsburgh Corporation(AP)
Ampco-Pittsburgh Corporation and its subsidiaries manufacture and sell custom-engineered equipment in the United States and internationally. It operates in two segments, Forged and Cast Rolls, and Air and Liquid Processing. The Forged and Cast Rolls segment produces forged hardened steel rolls used in cold rolling for the producers of steel, aluminum, and other metals; and cast iron and steel rolls for hot and cold strip mills, medium/heavy section mills, and plate mills. The Air and Liquid Processing segment manufactures finned tube and plate finned heat exchange coils for the commercial and industrial construction, as well as for process and utility industries; custom air handling systems used in commercial, institutional, and industrial buildings; and a line of centrifugal pumps for the refrigeration, power generation, and marine defense industries. The company was founded in 1929 and is based in Pittsburgh, Pennsylvania.
Advisors’ Opinion:
- [By ]
Stephen Moore and Herman Cain in Washington on Aug. 31, 2016, and June 20, 2014, respectively. (Photo: AP)
Why are critics of Moore and Cain saying they are ill-suited for nonpartisan roles?
- [By ]
The front page of the Jan. 28, 2019, edition of the National Enquirer featuring a story about Amazon founder and CEO Jeff Bezos' divorce. (Photo: AP)
- [By ]
Kraft Heinz disclosed it has received a subpoena from the SEC as part of an investigation into the company's procurement accounting policies. (Photo11: AP)
- [By ]
This Jan. 19, 1931 file photo shows Chicago mobster Al Capone at a football game. (Photo: AP)
Follow Josh Hafner on Twitter: @joshhafner
Top 10 Heal Care Stocks To Buy Right Now: Endologix, Inc.(ELGX)
Endologix, Inc., incorporated on June 2, 1993, is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Sales of the Company’s EVAR and EVAS platforms (including extensions and accessories) to hospitals in the United States and Europe, and to third-party international distributors provide the sole source of its revenue. It offers various accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.
The Company’s EVAR products consist of its EVAR Stent Graft and catheter delivery system, branded under the names Powerlink, IntuiTrak, AFX and VELA. The EVAR products consist of a cobalt chromium alloy stent covered by expanded polytetrafluoroethylene (PTFE) graft material (Stent Graft) and an accompanying delivery system. Once fixed in its proper position within the abdominal aorta, the EVAR device provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for AAA to rupture. Within the Company’s EVAR platform, AFX is marketed in the United States, Europe, New Zealand, Japan and Latin America, and Intuitrak sales are limited to Japan.
The Company’s EVAS pr! oduct is based on the Nellix platform to seal the aneurysm and provide blood flow to the legs through two blood lumens. The EVAS product consists of bilateral covered stents with endobags, a biocompatible polymer injected into the endobags to seal the aneurysm and a delivery system and polymer dispenser. The EVAS product seals the entire aneurysm sac, excluding the aneurysm sac and reducing the likelihood of future aneurysm rupture. Additionally, it has the potential to reduce the need for post procedural re-interventions. Biostable Polymer provides extended fixation and long-term stability.
The Company competes with Medtronic, Inc., W.L. Gore Inc. and Cook Medical Products, Inc.
Advisors’ Opinion:
- [By Max Byerly]
Endologix (NASDAQ:ELGX)’s stock had its “hold” rating restated by investment analysts at Oppenheimer in a report issued on Wednesday.
- [By Ethan Ryder]
These are some of the media stories that may have impacted Accern’s scoring:
Get Endologix alerts:
$30.85 Million in Sales Expected for Endologix, Inc. (ELGX) This Quarter (americanbankingnews.com) Zacks: Analysts Expect Endologix, Inc. (ELGX) Will Announce Earnings of -$0.25 Per Share (americanbankingnews.com) Don’t Sleep On Vienna: Stocks To Watch Now Are Tyson Foods, Inc. (TSN), Endologix, Inc. (ELGX) (gvtimes.com) current gravitate: Kohl’s Corporation, (NYSE: KSS), Endologix, Inc., (NASDAQ: ELGX) (nysetradingnews.com) Review of Financial analysis: General Electric Company (NYSE:GE), Endologix, Inc. (NASDAQ:ELGX), QEP Resources … (thestreetpoint.com)
Shares of NASDAQ:ELGX traded down $0.22 during midday trading on Monday, hitting $1.98. The stock had a trading volume of 1,591,600 shares, compared to its average volume of 642,128. The stock has a market capitalization of $186.36 million, a PE ratio of -4.13 and a beta of 0.03. The company has a current ratio of 1.90, a quick ratio of 1.20 and a debt-to-equity ratio of 5.37. Endologix has a fifty-two week low of $1.86 and a fifty-two week high of $6.72.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Endologix (ELGX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Brian Orelli]
Shares of Endologix (NASDAQ:ELGX) were down 37% on Friday after the medical device maker announceddisappointing earnings at market close on Thursday. Specifically, revenue decreased 7.9% year over year due to lower U.S. sales of AFX, its endovascular system to treat abdominal aortic aneurysms, and softness in Latin America.
Top 10 Heal Care Stocks To Buy Right Now: Ctrip.com International, Ltd.(CTRP)
Ctrip.com International, Ltd., together with its subsidiaries, provides travel services for hotel accommodations, transportation ticketing services, packaged tours, and corporate travel management in the Peoples Republic of China. It also offers independent leisure travelers bundled packaged-tour products, including group tours, semi-group tours, and private tours or packaged tours with various transportation arrangements, such as cruise, bus, or self-driving. In addition, the company provides integrated transportation and accommodation services; various value-added services, including transportation at destinations and tickets, insurance, visa services, and tour guides; supplier management and customer relationship management services; and car rental services. Further, it offers Internet-related advertising, aviation and train insurance selling, air-ticket delivery, online check-in, and online seat selection and flight dynamics services; and sells Property Management System, a hotel information software, as well as provides related maintenance services. Ctrip.com International, Ltd. was founded in 1999 and is headquartered in Shanghai, the Peoples Republic of China.
